Teva Pharmaceutical Industries reported $3.92B in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Aspen Pharmacare ZAR 13.32B 5.36B Dec/2025
Cipla INR 62.31B 3.04B Jun/2026
Dr.Reddys Laboratories INR 77.75B 3.17B Jun/2026
Guangzhou Baiy CNY 21.02B 4.38B Mar/2026
Jiangsu Hengrui CNY 5.52B 604.29M Mar/2026
Kalbe Farma IDR 8.36T 303.36B Mar/2026
Richter Gedeon HUF 157.88B 6.77B Mar/2026
Sh Fosun Pharma CNY 9.18B 2.12B Mar/2026
Sun Pharmaceuticals INR 117.43B 648.5M Jun/2026
Teva Pharmaceutical Industries USD 3.92B 691M Jun/2026